Showing 781 - 800 results of 1,139 for search '"preclinical"', query time: 0.07s Refine Results
  1. 781

    A Study to Check the Readiness of Final-Year Dental Students Vis-à-Vis to a Safe and an Independent Practitioner in Sultanate of Oman Amidst the Recent Pandemic by Triveni Nalawade, Sanjay Saraf, Rachappa Mallikarjuna, Belal Haj-Hamed, Siva Kumar, Nutayla Al Harthy, Mohamed Al Ismaily

    Published 2024-01-01
    “…The didactic online classes and preclinical sessions conducted while adhering to social distancing and other safety norms during the COVID-19 pandemic, were positively received by the students.…”
    Get full text
    Article
  2. 782

    Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications by Ahmad Vafaeian, Fateme Rajabi, Nima Rezaei

    Published 2025-02-01
    “…Direct TLR stimulation using different compounds has shown therapeutic benefits in preclinical studies. However, significant challenges exist, including off-target effects due to ubiquitous TLR expression and complex roles in immune responses. …”
    Get full text
    Article
  3. 783

    Relationship between skin temperature and blood flow during exposure to radio frequency energy: implications for device development by Georgia E. H. Robles, David A. Nelson

    Published 2025-01-01
    “…These results are being used in the development of a preclinical prototype for quick and easy detection of asymptomatic PAD in humans.…”
    Get full text
    Article
  4. 784
  5. 785

    DPP-4 Inhibitors as Treatments for Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis by Qixian Wang, Min Long, Hua Qu, Rufei Shen, Rui Zhang, Jing Xu, Xin Xiong, Hui Wang, Hongting Zheng

    Published 2018-01-01
    “…We thoroughly searched the Medline, Embase, PubMed, and Cochrane Library databases and ClinicalTrials.gov for studies concerning the use of DPP-4 inhibitors in patients with T1DM. Results. In preclinical trials, DPP-4 inhibitors improved the pathogenesis of T1DM. …”
    Get full text
    Article
  6. 786

    Proton Pump Inhibitors and Dementia: Physiopathological Mechanisms and Clinical Consequences by Gloria Ortiz-Guerrero, Diana Amador-Muñoz, Carlos Alberto Calderón-Ospina, Daniel López-Fuentes, Mauricio Orlando Nava Mesa

    Published 2018-01-01
    “…Although neurological side effects secondary to PPIs are rare, several preclinical reports indicate that PPIs might increase Aβ levels, interact with tau protein, and affect the neuronal microenvironment through several mechanisms. …”
    Get full text
    Article
  7. 787

    Oral Glutamine Supplement Inhibits Ascites Formation in Peritoneal Carcinomatosis Mouse Model by Ming-Jen Chen, Tsang-En Wang, Shu-Jung Tsai, Ching-Chung Lin, Chia-Yuan Liu, Horng-Yuan Wang, Shou-Chuan Shih, Yu-Jen Chen

    Published 2013-01-01
    “…Mean serum albumin levels were higher in the glutamine-supplemented group. Conclusions. This preclinical study showed that oral supplementation of glutamine may provide ascites-reducing activity in pancreatic cancer patients with PC, via a cell-mediated immunity-independent mechanism.…”
    Get full text
    Article
  8. 788

    Human neural stem cell–derived extracellular vesicles protect against ischemic stroke by activating the PI3K/AKT/mTOR pathway by Jiayi Wang, Mengke Zhao, Dong Fu, Meina Wang, Chao Han, Zhongyue Lv, Liang Wang, Jing Liu

    Published 2025-11-01
    “…To promote the translation of therapy based on human neural stem cell–derived extracellular vesicles from the bench to the bedside, we conducted a comprehensive preclinical study to evaluate the efficacy and safety of human neural stem cell–derived extracellular vesicles in the treatment of ischemic stroke. …”
    Get full text
    Article
  9. 789

    Role of exercise on ncRNAs and exosomal ncRNAs in preventing neurodegenerative diseases: a narrative review by Shangwu Liu, Runhong Zhang, Jamal Hallajzadeh

    Published 2025-02-01
    “…Research studies, both preclinical and clinical, that have documented the use of various exercises and their effects on ncRNAs and exosomal ncRNAs for the treatment of NDs have been compiled and enlisted from the PubMed database, spanning the time period from the year 2000 up to the current time. …”
    Get full text
    Article
  10. 790

    Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy by Chunhuan Jin, Xinyu Zhou, Minhui Xu, Hiroki Okanishi, Ryuichi Ohgaki, Yoshikatsu Kanai

    Published 2025-01-01
    “…Nanvuranlat (JPH203/KYT-0353), a LAT1 inhibitor, has shown antitumor activity in preclinical studies and efficacy in biliary tract cancer during clinical trials. …”
    Get full text
    Article
  11. 791

    Osteoarthritis synovium as a nidus for monosodium urate crystal deposition inducing severe gout studied by label‐free stimulated Raman scattering combined with synovial organoids by Ziyi Chen, Wenjuan Wang, Yaxin Chen, Minbiao Ji, Yinghui Hua

    Published 2025-01-01
    “…Therefore, this study aimed to investigate whether OA synovium acts as a nidus for MSU crystal deposition inducing severe gout flares, using label‐free, highly‐specific stimulated Raman scattering (SRS) microscopy combined with innovative preclinical models—synovial organoids. Crystal deposition, cellular phagocytosis, and subsequent inflammation intensity was imaged in ex vivo synovial organoids using SRS microscopy and other biochemical techniques. …”
    Get full text
    Article
  12. 792
  13. 793

    An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease by Jianglong Li, Haiyan Long, Shaoyi Chen, Zhendong Zhang, Shuang Li, Qi Liu, Jun Liu, Jiaru Cai, Liping Luo, Yucai Peng

    Published 2025-01-01
    “…Conclusions: Based on the preclinical immunogenicity and efficacy data, LVRNA007 could be a potential promising vaccine for prophylaxis of RSV infection.…”
    Get full text
    Article
  14. 794
  15. 795

    Kaempferol enhances ER-mitochondria coupling and protects motor neurons from mitochondrial dysfunction and ER stress in C9ORF72-ALS by Federica Pilotto, Paulien Hermine Smeele, Olivier Scheidegger, Rim Diab, Martina Schobesberger, Julieth Andrea Sierra-Delgado, Smita Saxena

    Published 2025-02-01
    “…Here, we investigated the mode of action and therapeutic effect of a naturally occurring dietary flavanol, kaempferol in preclinical rodent and human models of C9ORF72-ALS. …”
    Get full text
    Article
  16. 796

    Nanoparticle-based drug delivery system for Oral Cancer: Mechanism, challenges, and therapeutic potential by Nurhasni Hasan, Maryam Aftab, Muneeb Ullah, Phuong Tram Nguyen, Rina Agustina, Yulia Yusrini Djabir, Theofilus A. Tockary, Satoshi Uchida

    Published 2025-03-01
    “…Despite encouraging preclinical results, issues related to nanoparticle stability, safety, and regulatory considerations remain, necessitating additional research to connect experimental outcomes with clinical applications.…”
    Get full text
    Article
  17. 797

    Diabe-teach: a randomized controlled trial of a gamified approach to enhance medical undergraduates’ knowledge and comprehension of diabetes mellitus by Mariam Shadan, Heba Ismail, Fathima Hana Mohamed Naushad

    Published 2025-01-01
    “…A randomized controlled design involving 56 preclinical medical students at Dubai Medical College for Girls was used. …”
    Get full text
    Article
  18. 798

    Peptides as Versatile Regulators in Cancer Immunotherapy: Recent Advances, Challenges, and Future Prospects by Yu Lei, Jiacheng Liu, Yaowei Bai, Chuansheng Zheng, Dongyuan Wang

    Published 2025-01-01
    “…To address these challenges, a growing number of immunotherapy drugs have been investigated in clinical and preclinical applications. The diverse functionality of peptides has made them attractive as a therapeutic modality, and the global market for peptide-based therapeutics is witnessing significant growth. …”
    Get full text
    Article
  19. 799

    Novel Strategies for the Improvement of Stem Cells’ Transplantation in Degenerative Retinal Diseases by Simona Delia Nicoară, Sergiu Șușman, Oana Tudoran, Otilia Bărbos, Gabriela Cherecheș, Simion Aștilean, Monica Potara, Olga Sorițău

    Published 2016-01-01
    “…The feasibility of SCs based therapies for degenerative retinal diseases was proved in the preclinical setting. However, their translation into the clinical realm is limited by various factors: the immunogenicity of the cells, the stability of the cell phenotype, the predilection of SCs to form tumors in situ, the abnormality of the microenvironment, and the association of a synaptic rewiring. …”
    Get full text
    Article
  20. 800

    Perceptions and attitudes of medical students toward opioid education: A qualitative study by Angelina Luciano, Mara Schenker, Dawn L. Comeau, Courtney R. Yarbrough, Nicholas A. Giordano

    Published 2025-03-01
    “…Discussions revealed that the curriculum on opioid medications and their prescription in medical school is limited and varied, with most opportunities for learning arising during preclinical years. The quantity and quality of the opioid-related education experienced by participants during medical school impacted their perceived knowledge about opioids and, consequently, their confidence in treating pain. …”
    Get full text
    Article